References
Original article
Baudin, E. et al. Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial. Lancet https://doi.org/10.1016/S0140-6736(23)02554-0 (2024)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. FIRSTMAPPP prospectively charts the efficacy of sunitinib for phaeochromocytoma and paraganglioma. Nat Rev Clin Oncol 21, 335 (2024). https://doi.org/10.1038/s41571-024-00880-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-024-00880-4
- Springer Nature Limited